Literature DB >> 24845137

Biobanks in the United States: how to identify an undefined and rapidly evolving population.

Gregory J Boyer1, Warren Whipple, R Jean Cadigan, Gail E Henderson.   

Abstract

As part of a larger organizational study, we sought to survey biobanks in the United States. However, we encountered two problems with this population. First, no common definition of biobanks exists. Second, no census is available of these facilities from which to sample in order to implement a survey. In light of these problems, we employed a multifaceted approach using electronic searches of PubMed, RePORTER, and Google. In addition, we systematically searched for biobanks housed within universities that have NIH-designated Clinical and Translational Science Awards (CTSA). We expanded this part of the search by looking for biobanks among all members of the American Association of Medical Colleges (AAMC). Finally, we added banks to our database found previously by other researchers and banks found via correspondence with our colleagues. Our search strategy produced a database of 624 biobanks for which we were able to confirm contact information in order to conduct our online survey. Another 140 biobanks were identified but did not respond to our requests to confirm their existence or contact information. In order to maximize both the uniqueness of banks found and the greatest return on effort for each search, we suggest targeting resources that are already organized. In our work, these included the CTSA, AAMC, and part of the Google searches. We contend that our search provides a model for analysis of new fields of research and/or rapidly evolving industries. Furthermore, our approach demonstrates that with the appropriate tools it is possible to develop a systematic and comprehensive database to investigate undefined populations.

Mesh:

Year:  2012        PMID: 24845137      PMCID: PMC4076972          DOI: 10.1089/bio.2012.0034

Source DB:  PubMed          Journal:  Biopreserv Biobank        ISSN: 1947-5543            Impact factor:   2.300


  6 in total

1.  Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical record.

Authors:  Marylyn D Ritchie; Joshua C Denny; Dana C Crawford; Andrea H Ramirez; Justin B Weiner; Jill M Pulley; Melissa A Basford; Kristin Brown-Gentry; Jeffrey R Balser; Daniel R Masys; Jonathan L Haines; Dan M Roden
Journal:  Am J Hum Genet       Date:  2010-04-01       Impact factor: 11.025

2.  Do we need a uniform regulatory system for biobanks across Europe?

Authors:  Jane Kaye
Journal:  Eur J Hum Genet       Date:  2006-02       Impact factor: 4.246

3.  Identification of polymorphisms in the 3'-untranslated region of the human pregnane X receptor (PXR) gene associated with variability in cytochrome P450 3A (CYP3A) metabolism.

Authors:  L Oleson; L L von Moltke; D J Greenblatt; M H Court
Journal:  Xenobiotica       Date:  2010-02       Impact factor: 1.908

4.  Massively parallel signature sequencing and bioinformatics analysis identifies up-regulation of TGFBI and SOX4 in human glioblastoma.

Authors:  Biaoyang Lin; Anup Madan; Jae-Geun Yoon; Xuefeng Fang; Xiaowei Yan; Taek-Kyun Kim; Daehee Hwang; Leroy Hood; Gregory Foltz
Journal:  PLoS One       Date:  2010-04-19       Impact factor: 3.240

5.  A proposed schema for classifying human research biobanks.

Authors:  Peter H Watson; Rebecca O Barnes
Journal:  Biopreserv Biobank       Date:  2011-10-03       Impact factor: 2.300

6.  An empirical examination of the management of return of individual research results and incidental findings in genomic biobanks.

Authors:  Gina Johnson; Frances Lawrenz; Mao Thao
Journal:  Genet Med       Date:  2012-02-23       Impact factor: 8.822

  6 in total
  12 in total

1.  Self-reported race and ethnicity of US biobank participants compared to the US Census.

Authors:  Elizabeth Gross Cohn; Nalo Hamilton; Elaine L Larson; Janet K Williams
Journal:  J Community Genet       Date:  2017-06-16

2.  "Forward-Thinking" in U.S. Biobanking.

Authors:  R Jean Cadigan; Teresa P Edwards; Dragana Lassiter; Arlene M Davis; Gail E Henderson
Journal:  Genet Test Mol Biomarkers       Date:  2017-01-24

3.  Access policies in biobank research: what criteria do they include and how publicly available are they? A cross-sectional study.

Authors:  Holger Langhof; Hannes Kahrass; Sören Sievers; Daniel Strech
Journal:  Eur J Hum Genet       Date:  2016-12-21       Impact factor: 4.246

4.  Stewardship practices of U.S. biobanks.

Authors:  Gail E Henderson; Teresa P Edwards; R Jean Cadigan; Arlene M Davis; Catherine Zimmer; Ian Conlon; Bryan J Weiner
Journal:  Sci Transl Med       Date:  2013-12-11       Impact factor: 17.956

5.  Human embryos and eggs: from long-term storage to biobanking.

Authors:  Françoise Baylis; Heather Widdows
Journal:  Monash Bioeth Rev       Date:  2015-12

Review 6.  A critical analysis of cancer biobank practices in relation to biospecimen quality.

Authors:  Amanda Rush; Kevin Spring; Jennifer A Byrne
Journal:  Biophys Rev       Date:  2015-10-22

7.  Biobanks containing clinical specimens: defining characteristics, policies, and practices.

Authors:  Teresa Edwards; R Jean Cadigan; James P Evans; Gail E Henderson
Journal:  Clin Biochem       Date:  2013-12-15       Impact factor: 3.281

8.  Willingness of women to participate in obstetrical and pediatric research involving biobanks.

Authors:  Renate D Savich; Beth B Tigges; Lisbeth Iglesias Rios; Joanne McCloskey; Kristine Tollestrup; Robert D Annett
Journal:  J Community Genet       Date:  2019-11-28

9.  Underutilization of specimens in biobanks: an ethical as well as a practical concern?

Authors:  R Jean Cadigan; Eric Juengst; Arlene Davis; Gail Henderson
Journal:  Genet Med       Date:  2014-04-24       Impact factor: 8.822

10.  Characterizing biobank organizations in the U.S.: results from a national survey.

Authors:  Gail E Henderson; R Jean Cadigan; Teresa P Edwards; Ian Conlon; Anders G Nelson; James P Evans; Arlene M Davis; Catherine Zimmer; Bryan J Weiner
Journal:  Genome Med       Date:  2013-01-25       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.